RxDoctor Payments Data

Brandi Wisenbaker-Valenzuela

Physician Assistant · Houston, TXNPI 1104001239

Payments from drug & device makers

$4,627in general payments, 2019–2025

Across 219 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$658
  • AbbVie$609
  • Amgen$277
  • Lilly USA, LLC$250
  • Pfizer$235
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,627 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$76,460
MounjaroTirzepatide17$29,026
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$16,288
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$3,007
SynthroidLevothyroxine Sodium19$2,145
Gabapentin67$1,852
Albuterol Sulfate HfaAlbuterol Sulfate46$1,627
Fluticasone Propionate42$953
Bupropion XlBupropion Hcl41$883
Montelukast Sodium67$844
Cefdinir45$769
Estradiol29$746
Sertraline Hcl51$713
Levothyroxine Sodium59$691
Ondansetron OdtOndansetron57$679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,088$76,46065 claims
Lilly USA, LLCMounjaro$250$29,02617 claims
AbbVieSynthroid$609$2,14519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →